GPER1 and pancreatic adenocarcinoma: Through such interactions, GPER/GPR30 could probably modulate the tumor microenvironment and through this mediate TGCC progression and aggressiveness, especially by inducing epithelial-mesenchymal-transition (97, 98), as has been reported in breast cancer (98, 99) and in pancreatic adenocarcinoma (100).